Navigation Links
Louisiana Tech physicists highlight top 10 science stories of 2008
Date:1/7/2009

cause of the way they are composed, they can shuffle waves away from an object.

"These metamaterials, undreamed of a few years ago, may prove to be one of the key technologies of the 21st century," explains Sawyer. "Already people are beginning to think of innovative ways of applying these materials. While a lot of discussion has been about 'cloaking devices,' there is a lot of promise in new optical devices and coatings."

In addition to the recognition by Discover, Time magazine also acknowledges the significance of these two projects, ranking the LHC story at #1 on its Top 10 of 2008 list and the "invisibility cloak" story at #7.

"This recognition by Discover and Time magazines confirms that the physics faculty at Louisiana Tech are contributing significantly to relevant and vital science discoveries," says Dr. Stan Napper, dean of Louisiana Tech's College of Engineering and Science. "Our students are directly benefiting from these outstanding researchers who are also outstanding educators."

"Person for person, we have the finest physics faculty in the country," says Sawyer. "Our faculty offer students at both the undergraduate and graduate level a wide range of opportunities for research at the forefront of science."


'/>"/>

Contact: Dave Guerin
dguerin@latech.edu
318-257-4854
Louisiana Tech University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Louisiana Tech researchers investigate tracking, sensors to assist Air Force
2. Louisiana Tech researchers feature drug reformulation in prestigious journal
3. Wetlands restoration not a panacea for Louisiana coast
4. UC San Diego physicists tackle knotty puzzle
5. Penn biophysicists create new model for protein-cholesterol interactions in brain and muscle tissue
6. How do bacteria swim? Brown physicists explain
7. September Geology and GSA Today media highlights
8. Highlights from the September 2007 Journal of the American Dietetic Association
9. AGU journal highlights -- Sept. 6, 2007
10. IDEMA Reveals Program Highlights for DISKCON USA 2007
11. IDEMA Reveals Program Highlights for DISKCON USA 2007
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):H1N1 influenza adopted novel strategy to move from birds to humans 2H1N1 influenza adopted novel strategy to move from birds to humans 3H1N1 influenza adopted novel strategy to move from birds to humans 4Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 2Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 3Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 4Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 5Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 6Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 7Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 8Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 9Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 10Brooding fishes take up nutrients from their own children 2Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Associat 12518 1Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Associat 12518 2Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Associat 12518 3Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Associat 12518 4Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Associat 12518 5Intarcia Therapeutics Inc Presents ITCA 650 Phase 1b Study Results as a Late Breaker at the American Diabetes Association 69th Scientific Sessions 12513 1Intarcia Therapeutics Inc Presents ITCA 650 Phase 1b Study Results as a Late Breaker at the American Diabetes Association 69th Scientific Sessions 12513 2Intarcia Therapeutics Inc Presents ITCA 650 Phase 1b Study Results as a Late Breaker at the American Diabetes Association 69th Scientific Sessions 12513 3Intarcia Therapeutics Inc Presents ITCA 650 Phase 1b Study Results as a Late Breaker at the American Diabetes Association 69th Scientific Sessions 12513 4Glowing TV Screens Keeping Americans Up at Night 48152 1Glowing TV Screens Keeping Americans Up at Night 48152 2